FDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor EffectZhiwei Yao, Xiaolong Fu|Journal of the Association for Research in Otolaryngology|2024Cited by 3